Public Citizen – PharmaLive

Advocacy Group and FDA Advisor Call for a Moratorium on Opioid Approvals

Anesthetic and Analgesic Drug Products Advisory Committee, Crisis, FDA, FDA/Regulatory, Indiana, Opioids, Opioids, Outbreaks, Public Citizen, Substance Abuse

As America continues to grapple with the opioid crisis, nonprofit advocacy group Public Citizen is calling for the U.S. Food and Drug Administration (FDA) to place a moratorium on the approval of any new opioid medications.

March 22, 2019/by BioSpace

Consumer Group Pressures FDA to Pull Takeda’s Gout Drug from Market

FDA, Gout, IMS Health, Public Citizen, The New England Journal of Medicine (NEJM), Therapeutics

Consumer advocacy group Public Citizen petitioned the FDA to pull Takeda’s gout treatment Uloric (febuxostat) off the market.

June 22, 2018/by Administrator

Watchdog urges FDA to revoke approval of Genzyme surgical implant

Advocacy Groups, Approvals, Biotech/Biopharma, Consumer Watchdogs, FDA/Regulatory, Health, Implants, Legal, Medical Devices, Off-Labe Use, Public Citizen, Surgery

Consumer watchdog Public Citizen said it petitioned U.S. health regulators to withdraw approval of Sanofi SA’s Seprafilm and order a recall, saying the surgical implant has been associated with side […]

July 7, 2015/by Reuters Health

Watchdog accuses FDA of wrongly expanding Vanda sleep drug use

FDA/Regulatory, Health, Insomnia, Public Citizen, Therapeutics

U.S. regulators have inappropriately expanded the approved use of Vanda Pharmaceuticals Inc’s sleep disorder drug Hetlioz beyond its original indication for use in blind people, the consumer watchdog Public Citizen […]

June 11, 2015/by Reuters Health